Old Web
English
Sign In
Acemap
>
authorDetail
>
Lucy J. Elrick
Lucy J. Elrick
Glasgow Royal Infirmary
Imatinib
Population
Immunology
Stem cell
Cancer research
4
Papers
732
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
imatinib in primary CML, but does not eliminate the quiescent fraction Dasatinib (BMS-354825) targets an earlier progenitor population than
2013
Joanne C. Mountford
Tessa L. Holyoake
Mhairi Copland
Ashley Hamilton
Lucy J. Elrick
Janet W. Baird
Elaine K. Allan
Show All
Source
Cite
Save
Citations (0)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
2006
Blood
Mhairi Copland
Ashley Hamilton
Lucy J. Elrick
Janet W. Baird
Elaine K. Allan
Niove E. Jordanides
Martin Barow
Joanne C. Mountford
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (594)
Punish the parent not the progeny
2005
Blood
Lucy J. Elrick
Heather G. Jørgensen
Joanne C. Mountford
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (135)
Dasatinib (BMS-354825) Has Increased Activity Against Bcr-Abl Compared to Imatinib in Primary CML Cells In Vitro , but Does Not Eradicate Quiescent CML Stem Cells.
2005
Blood
Mhairi Copland
Ashley Hamilton
Janet W. Baird
Martin Barow
Elaine K. Allan
Lucy J. Elrick
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (3)
1